NewsRamp provides syndicated and curated news distribution and marketing services for major newswires.
September 6, 2025 — Baxdrostat Phase 2 trial shows 5% blood pressure reduction and 55% less urine albumin in chronic kidney disease patients. Novel aldosterone inhibitor may delay kidney disease progression.
September 5, 2025 — Helix BioPharma cancels GEM financing deal, seeks alternative funding for cancer drug development. TSX:HBP updates strategic capital approach for oncology pipeline advancement.
September 5, 2025 — HealthLynked completes reverse stock split while expanding AI healthcare platform and telemedicine services. Strategic move strengthens capital structure and supports potential uplisting opportunities.
September 5, 2025 — Nursa, founded by Curtis Anderson, revolutionizes healthcare staffing with digital platform connecting 400,000+ nurses to 3,400+ facilities. Solving nursing shortage crisis through technology.
September 5, 2025 — NCI halts funding for pediatric brain cancer trials after 26 years, shifting focus to broader oncology research. CNS Pharmaceuticals becomes crucial for childhood cancer treatment development.
September 5, 2025 — HealthLynked completes reverse stock split to strengthen market position while expanding AI healthcare platform and telemedicine services for improved patient care coordination and cost savings.
September 5, 2025 — Shala Hormone Health launches NOURISH², a dual-action prebiotic and enzyme blend for gut health and nutrient absorption. Available at shala.com for $34.99.
September 4, 2025 — Study shows 48% rise in hypertensive kidney disease deaths over 25 years, with Black individuals facing triple the mortality rate. Urgent call for better BP management.
September 4, 2025 — Study reveals less than 6% of Americans use salt substitutes despite proven benefits for hypertension management. Research presented at AHA Hypertension Sessions shows major public health opportunity.
September 4, 2025 — Devonshire at Erickson Senior Living enhances senior wellness with personalized fitness programs led by experts, offering classes and state-of-the-art facilities for active aging.
September 4, 2025 — Brook.ai's remote care platform helps rural clinics achieve HEDIS quality measures, secure incentives, and improve patient outcomes through AI and human support.
September 4, 2025 — Clene's CNM-Au8 shows improved mitochondrial function & reduced inflammation in Parkinson's disease models. Breakthrough neuroprotective therapy potential for millions affected.
September 4, 2025 — Dr. Callum Potts leads CCRM Miami's fertility clinic with personal IVF experience. Comprehensive care includes IVF, egg freezing & genetic testing all under one roof in Aventura.
September 4, 2025 — Soligenix announces ebolavirus vaccines with ThermoVax platform remain potent after 2 years at 40°C, enhancing global distribution and pandemic readiness.
September 4, 2025 — Oncotelic Therapeutics updates pipeline under CEO Dr. Vuong Trieu, inventor of $2.9B Abraxane cancer drug. Clinical-stage biopharma targeting high-unmet-need cancers.
September 4, 2025 — Soligenix receives FDA orphan drug designation for dusquetide treating Behçet's disease following successful phase 2a trial results showing efficacy and safety.
September 4, 2025 — Fifty1 Labs publishes groundbreaking AI research in oncology real-world evidence, revolutionizing drug repurposing and global treatment access through advanced statistical frameworks.
September 4, 2025 — New research reveals SOX6 protein targeting could repair myelin in multiple sclerosis patients. Clene Inc. advances related treatments. Breakthrough for MS therapy development.
September 4, 2025 — Izotropic's IzoView Breast CT detects cancers as small as 2mm, improving early diagnosis. CEO discusses AI advancements and commercialization in Europe/U.S. markets.
September 4, 2025 — Branded Legacy acquires Vancouver facility for addiction treatment R&D. New GMP-compliant lab to develop harm reduction technologies and intranasal delivery devices for opioid crisis response.